Hsiu‐Hao Chang

2.3k total citations
101 papers, 1.4k citations indexed

About

Hsiu‐Hao Chang is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hsiu‐Hao Chang has authored 101 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 27 papers in Molecular Biology and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hsiu‐Hao Chang's work include Neuroblastoma Research and Treatments (20 papers), Acute Lymphoblastic Leukemia research (20 papers) and Acute Myeloid Leukemia Research (13 papers). Hsiu‐Hao Chang is often cited by papers focused on Neuroblastoma Research and Treatments (20 papers), Acute Lymphoblastic Leukemia research (20 papers) and Acute Myeloid Leukemia Research (13 papers). Hsiu‐Hao Chang collaborates with scholars based in Taiwan, United States and United Kingdom. Hsiu‐Hao Chang's co-authors include Meng‐Yao Lu, Shiann‐Tarng Jou, Kai‐Hsin Lin, Yung‐Li Yang, Dong‐Tsamn Lin, Wen‐Ming Hsu, Yung‐Ming Jeng, Min‐Chuan Huang, Hsinyu Lee and Mark Yen‐Ping Kuo and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hsiu‐Hao Chang

98 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsiu‐Hao Chang Taiwan 23 420 317 248 240 232 101 1.4k
Yung‐Li Yang Taiwan 19 358 0.9× 364 1.1× 175 0.7× 179 0.7× 339 1.5× 84 1.2k
Kimikazu Matsumoto Japan 20 270 0.6× 567 1.8× 237 1.0× 171 0.7× 370 1.6× 122 1.3k
Bernhard Meister Austria 22 542 1.3× 542 1.7× 437 1.8× 162 0.7× 370 1.6× 65 1.7k
Ronit Elhasid Israel 22 437 1.0× 406 1.3× 250 1.0× 82 0.3× 253 1.1× 113 1.8k
D Niethammer Germany 21 392 0.9× 399 1.3× 282 1.1× 416 1.7× 199 0.9× 96 1.5k
P Lutz France 24 247 0.6× 477 1.5× 283 1.1× 284 1.2× 323 1.4× 45 1.4k
Hiroaki Goto Japan 22 485 1.2× 634 2.0× 364 1.5× 133 0.6× 476 2.1× 157 1.7k
Patrick Lutz France 26 374 0.9× 492 1.6× 490 2.0× 264 1.1× 462 2.0× 62 2.3k
John L. Reagan United States 20 403 1.0× 282 0.9× 580 2.3× 130 0.5× 101 0.4× 107 1.5k
Hyo Seop Ahn South Korea 27 700 1.7× 729 2.3× 413 1.7× 209 0.9× 424 1.8× 162 2.4k

Countries citing papers authored by Hsiu‐Hao Chang

Since Specialization
Citations

This map shows the geographic impact of Hsiu‐Hao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiu‐Hao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiu‐Hao Chang more than expected).

Fields of papers citing papers by Hsiu‐Hao Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiu‐Hao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiu‐Hao Chang. The network helps show where Hsiu‐Hao Chang may publish in the future.

Co-authorship network of co-authors of Hsiu‐Hao Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiu‐Hao Chang. A scholar is included among the top collaborators of Hsiu‐Hao Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiu‐Hao Chang. Hsiu‐Hao Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Meng‐Ju, et al.. (2022). TCF3-HLF-Positive Acute Lymphoblastic Leukemia Resembling Burkitt Leukemia: Cell Morphologic and Immunophenotypic Findings. JCO Precision Oncology. 6(6). e2200236–e2200236. 1 indexed citations
2.
Chang, Ya‐Hsuan, Shiann‐Tarng Jou, Chien‐Yu Lin, et al.. (2022). A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols. PubMed Central. 1 indexed citations
3.
Lin, Neng‐Yu, Syue‐Ting Chen, Meng‐Yao Lu, et al.. (2022). C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma. Oncogenesis. 11(1). 8–8. 11 indexed citations
4.
5.
Chang, Hsiu‐Hao, Meng‐Yao Lu, Yung‐Li Yang, et al.. (2021). Role of eltrombopag in severe aplastic anemia treatment in children. Pediatrics & Neonatology. 62(6). 655–657. 2 indexed citations
6.
Hsu, Wei-Yun, Hsiu‐Hao Chang, Meng‐Yao Lu, et al.. (2020). Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan. Pediatrics & Neonatology. 61(4). 393–398. 3 indexed citations
7.
Cheng, Jason Chia‐Hsien, Yu‐Hsuan Chen, Meng‐Yao Lu, et al.. (2019). Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients After Receiving Multimodality Treatment and Helical Tomotherapy. Anticancer Research. 39(4). 2207–2215. 4 indexed citations
8.
Kuo, Ching‐Te, Wei‐Min Chen, Si‐Chen Lee, et al.. (2018). Facilitating tumor spheroid-based bioassays and in vitro blood vessel modeling via bioinspired self-formation microstructure devices. Lab on a Chip. 18(16). 2453–2465. 8 indexed citations
9.
Li, Meng‐Ju, Ni‐Chung Lee, Yung‐Li Yang, et al.. (2015). Long-term outcome for Down syndrome patients with hematopoietic disorders. Journal of the Formosan Medical Association. 115(2). 94–99. 2 indexed citations
10.
Li, Meng‐Ju, Yung‐Li Yang, Ni‐Chung Lee, et al.. (2015). Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia. Journal of the Formosan Medical Association. 115(9). 801–806. 10 indexed citations
11.
Chang, Hsiu‐Hao, Chia‐Hua Chen, Yung‐Feng Liao, et al.. (2013). β-1,4-Galactosyltransferase III Enhances Invasive Phenotypes Via β1-Integrin and Predicts Poor Prognosis in Neuroblastoma. Clinical Cancer Research. 19(7). 1705–1716. 39 indexed citations
12.
Ho, Wan‐Ling, Hsiu‐Hao Chang, Yung‐Ming Jeng, et al.. (2013). B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma. Cancer Science. 104(12). 1600–1608. 39 indexed citations
13.
McGeachie, Michael J., Andy Wu, Hsiu‐Hao Chang, et al.. (2012). Predicting inhaled corticosteroid response in asthma with two associated SNPs. The Pharmacogenomics Journal. 13(4). 306–311. 22 indexed citations
14.
Hsu, Wen‐Ming, Yung-Feng Liao, Hsiu‐Hao Chang, et al.. (2011). B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via β1 Integrin Signaling in Neuroblastoma. American Journal Of Pathology. 179(3). 1394–1404. 35 indexed citations
15.
Chen, Chang‐Mu, Hsiu‐Hao Chang, Kai‐Hsin Lin, et al.. (2011). Functional recovery of cranial nerves VII and VIII after hypofractionated CyberKnife radiosurgery in a neuroblastoma patient with cerebellopontine angle metastasis—Case report. Clinical Neurology and Neurosurgery. 114(1). 50–53. 3 indexed citations
16.
Chang, Hsiu‐Hao, Hsinyu Lee, Po‐Nien Tsao, et al.. (2010). Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma. Clinical Cancer Research. 16(17). 4411–4420. 41 indexed citations
17.
Yang, Yung‐Li, Jiann-Shiuh Chen, Kai‐Hsin Lin, et al.. (2010). Multiplex Reverse Transcription-Polymerase Chain Reaction as Diagnostic Molecular Screening of 4 Common Fusion Chimeric Genes in Taiwanese Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 32(8). e323–e330. 8 indexed citations
18.
Chang, Hsiu‐Hao, et al.. (2009). Glycogen Storage Disease Type Ib: The First Case in Taiwan. Pediatrics & Neonatology. 50(3). 125–128. 3 indexed citations
19.
Hsu, Wen‐Ming, Hsinyu Lee, Hsueh‐Fen Juan, et al.. (2008). Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis. Clinical Cancer Research. 14(19). 6237–6245. 25 indexed citations
20.
Chern, Jimmy P.S., Kai‐Hsin Lin, Meng‐Yao Lu, et al.. (2007). β‐Thalassemia major births after National Screening Program in Taiwan. Pediatric Blood & Cancer. 50(1). 58–61. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yung‐Li Yang Breakdown of academic impact, for papers by Kimikazu Matsumoto Breakdown of academic impact, for papers by Bernhard Meister Breakdown of academic impact, for papers by Ronit Elhasid Breakdown of academic impact, for papers by D Niethammer Breakdown of academic impact, for papers by P Lutz Breakdown of academic impact, for papers by Hiroaki Goto Breakdown of academic impact, for papers by Patrick Lutz Breakdown of academic impact, for papers by John L. Reagan Breakdown of academic impact, for papers by Hyo Seop Ahn
Rankless by CCL
2026